A major contributor to the lack of medicines in developing countries is an intellectual property regime that allows proprietary drug companies with intellectual property monopolies to charge high prices and maximize profit.
Eitan Neidich, Alon B. Neidich, David A. Axelrod, MD, and John P. Roberts, MD
Geographic disparities in availability of organs for transplant have spawned for-profit companies that help patients get on waitlists in more than one region and arrange travel for them if an organ becomes available.
With the U.S. Supreme Court likely to decide on the constitutionality of the Affordable Care Act, it is instructive to understand the relevant policy positions of the largest physician organization in the country.
The picture that emerges from study of physician economic behavior is mixed, but from the intensity of responses by some professional societies to Medicare's coding modifier proposal, it appears that economic incentives matter a lot to many of their members.
If the American Society for Reproductive Medicine's recommendations for egg-donor compensation limits have been successful, they violate antitrust law. If they are ineffective, egg donors are not being sufficiently protected against coercion and commodification.
The ACA does not, as intended, provide equal access to health care, due to financial and geographic barriers, and low coverage limits access to habilitative and rehabilitative services.
AMA J Ethics. 2015;17(6):553-557. doi:
10.1001/journalofethics.2015.17.6.pfor1-1506.
The Department of Health and Human Service's decision to include a religious exemption to its requirement that private health plans cover contraception without patient cost-sharing raises questions about whether such an exemption appropriately balances the needs, beliefs, rights, and obligations of all affected.
Extending immunosuppressive drug coverage for the lifetime of kidney patients, instead of only covering dialysis, would be a cost-effective way for the federal government to reduce the costs of posttransplant care while improving clinical outcomes for patients.
Bruce C. Vladeck, PhD, Sander Florman, MD, and Jonathan Cooper, JD
The United Network for Organ Sharing’s geographic allocation system is outdated and inequitable, particularly in light of improved ability to transport organs. Allocation should be based on common medical criteria, not accidents of geography.